| MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 3161 | 2018 |
| F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients FL Giesel, B Hadaschik, J Cardinale, J Radtke, M Vinsensia, W Lehnert, ... European journal of nuclear medicine and molecular imaging 44, 678-688, 2017 | 623 | 2017 |
| Multiparametric magnetic resonance imaging (MRI) and MRI–transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen JP Radtke, C Schwab, MB Wolf, MT Freitag, CD Alt, C Kesch, ... European urology 70 (5), 846-853, 2016 | 328 | 2016 |
| Classification of cancer at prostate MRI: deep learning versus clinical PI-RADS assessment P Schelb, S Kohl, JP Radtke, M Wiesenfarth, P Kickingereder, ... Radiology 293 (3), 607-617, 2019 | 316 | 2019 |
| The value of PSA density in combination with PI-RADS™ for the accuracy of prostate cancer prediction FA Distler, JP Radtke, D Bonekamp, C Kesch, HP Schlemmer, ... The Journal of urology 198 (3), 575-582, 2017 | 258 | 2017 |
| Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion … JP Radtke, TH Kuru, S Boxler, CD Alt, IV Popeneciu, C Huettenbrink, ... The Journal of urology 193 (1), 87-94, 2015 | 233 | 2015 |
| Radiomic machine learning for characterization of prostate lesions with MRI: comparison to ADC values D Bonekamp, S Kohl, M Wiesenfarth, P Schelb, JP Radtke, M Götz, ... Radiology 289 (1), 128-137, 2018 | 220 | 2018 |
| Combined clinical parameters and multiparametric magnetic resonance imaging for advanced risk modeling of prostate cancer—patient-tailored risk stratification can reduce … JP Radtke, M Wiesenfarth, C Kesch, MT Freitag, CD Alt, K Celik, F Distler, ... European urology 72 (6), 888-896, 2017 | 200 | 2017 |
| Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer MT Freitag, JP Radtke, BA Hadaschik, A Kopp-Schneider, M Eder, ... European journal of nuclear medicine and molecular imaging 43, 70-83, 2016 | 179 | 2016 |
| Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI … MT Freitag, JP Radtke, A Afshar-Oromieh, MC Roethke, BA Hadaschik, ... European journal of nuclear medicine and molecular imaging 44, 776-787, 2017 | 165 | 2017 |
| Adversarial networks for the detection of aggressive prostate cancer S Kohl, D Bonekamp, HP Schlemmer, K Yaqubi, M Hohenfellner, ... arXiv preprint arXiv:1702.08014, 2017 | 162 | 2017 |
| Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image‐fusion guided transperineal prostate biopsy in patients with a previous … NL Hansen, C Kesch, T Barrett, B Koo, JP Radtke, D Bonekamp, ... BJU international 120 (5), 631-638, 2017 | 148 | 2017 |
| Impact of complete bladder neck preservation on urinary continence, quality of life and surgical margins after radical prostatectomy: a randomized, controlled, single blind trial JN Nyarangi-Dix, JP Radtke, B Hadaschik, S Pahernik, M Hohenfellner The Journal of urology 189 (3), 891-898, 2013 | 138 | 2013 |
| Intraindividual comparison of 18F-PSMA-1007 PET/CT, multiparametric MRI, and radical prostatectomy specimens in patients with primary prostate cancer: a retrospective, proof-of … C Kesch, M Vinsensia, JP Radtke, HP Schlemmer, M Heller, E Ellert, ... Journal of Nuclear Medicine 58 (11), 1805-1810, 2017 | 122 | 2017 |
| “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now J Grummet, MA Gorin, R Popert, T O’Brien, AD Lamb, B Hadaschik, ... Prostate cancer and prostatic diseases 23 (1), 62-65, 2020 | 111 | 2020 |
| Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion … JP Radtke, S Boxler, TH Kuru, MB Wolf, CD Alt, IV Popeneciu, ... Prostate cancer and prostatic diseases 18 (3), 288-296, 2015 | 92 | 2015 |
| Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer A Borkowetz, I Platzek, M Toma, M Laniado, G Baretton, M Froehner, ... BJU international 116 (6), 873-879, 2015 | 91 | 2015 |
| Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging/transrectal ultrasonography–fusion biopsy S Tschirdewahn, M Wiesenfarth, D Bonekamp, L Püllen, H Reis, A Panic, ... European urology focus 7 (6), 1300-1307, 2021 | 70 | 2021 |
| Biochemical recurrence of prostate cancer: initial results with [18F] PSMA-1007 PET/CT FL Giesel, L Will, C Kesch, M Freitag, C Kremer, J Merkle, OC Neels, ... Journal of Nuclear Medicine 59 (4), 632-635, 2018 | 69 | 2018 |
| Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy‐naïve patients A Borkowetz, B Hadaschik, I Platzek, M Toma, G Torsev, T Renner, ... BJU international 121 (1), 53-60, 2018 | 65 | 2018 |